18143-Endometrial Cancer-NA-631

Endometrial Cancer

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number:

  • Address

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.